3SBio Executes 8.52 Million-Share Buy-back in June, Cutting Issued Shares to 2.53 Billion

Bulletin Express07-02

Hong Kong-listed biopharmaceutical group 3SBio Inc. reported that it repurchased 8.52 million ordinary shares in June 2026, transferring all of them into treasury stock.

The buy-backs, conducted on 22, 25 and 26 June at average prices of HKD 15.52, HKD 16.00 and HKD 15.91 per share respectively, amounted to an estimated aggregate outlay of about HKD 135.50 million. These transactions were carried out under the general mandate approved on 25 June 2025.

Following the repurchases:

• Issued shares (excluding treasury stock) decreased by 8.52 million to 2.53 billion, a 0.34% contraction versus May-end. • Treasury shares stood at 8.52 million. • Total issued shares (including treasury stock) remained unchanged at 2.54 billion. • Authorised share capital was unchanged at 50 billion shares with a par value of USD 0.00001 each, equivalent to USD 0.50 million.

3SBio confirmed that its public float remained above the Hong Kong Main Board’s minimum 25% threshold as at 30 June 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1123839414?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-02 17:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1123839414","market":"hk","top_or_hot":-1,"title":"3SBio Executes 8.52 Million-Share Buy-back in June, Cutting Issued Shares to 2.53 Billion","media":"Bulletin Express","content":"<p>Hong Kong-listed biopharmaceutical group 3SBio Inc. reported that it repurchased 8.52 million ordinary shares in June 2026, transferring all of them into treasury stock.</p>\n<p>The buy-backs, conducted on 22, 25 and 26 June at average prices of HKD 15.52, HKD 16.00 and HKD 15.91 per share respectively, amounted to an estimated aggregate outlay of about HKD 135.50 million. These transactions were carried out under the general mandate approved on 25 June 2025.</p>\n<p>Following the repurchases:</p>\n<p>• Issued shares (excluding treasury stock) decreased by 8.52 million to 2.53 billion, a 0.34% contraction versus May-end.  \n• Treasury shares stood at 8.52 million.  \n• Total issued shares (including treasury stock) remained unchanged at 2.54 billion.  \n• Authorised share capital was unchanged at 50 billion shares with a par value of USD 0.00001 each, equivalent to USD 0.50 million.</p>\n<p>3SBio confirmed that its public float remained above the Hong Kong Main Board’s minimum 25% threshold as at 30 June 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3SBio Executes 8.52 Million-Share Buy-back in June, Cutting Issued Shares to 2.53 Billion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3SBio Executes 8.52 Million-Share Buy-back in June, Cutting Issued Shares to 2.53 Billion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-07-02 17:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Hong Kong-listed biopharmaceutical group 3SBio Inc. reported that it repurchased 8.52 million ordinary shares in June 2026, transferring all of them into treasury stock.</p>\n<p>The buy-backs, conducted on 22, 25 and 26 June at average prices of HKD 15.52, HKD 16.00 and HKD 15.91 per share respectively, amounted to an estimated aggregate outlay of about HKD 135.50 million. These transactions were carried out under the general mandate approved on 25 June 2025.</p>\n<p>Following the repurchases:</p>\n<p>• Issued shares (excluding treasury stock) decreased by 8.52 million to 2.53 billion, a 0.34% contraction versus May-end.  \n• Treasury shares stood at 8.52 million.  \n• Total issued shares (including treasury stock) remained unchanged at 2.54 billion.  \n• Authorised share capital was unchanged at 50 billion shares with a par value of USD 0.00001 each, equivalent to USD 0.50 million.</p>\n<p>3SBio confirmed that its public float remained above the Hong Kong Main Board’s minimum 25% threshold as at 30 June 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01530","symbol_name":"三生制药","start_time":0,"source_url":"","article_id":"1123839414","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1123839414","pubTimestamp":1782985572,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Hong Kong-listed biopharmaceutical group 3SBio Inc. reported that it repurchased 8.52 million ordinary shares in June 2026, transferring all of them into treasury stock. The buy-backs, conducted on...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01530":"三生制药"},"translate_title":"三生制药6月执行852万股回购，已发行股份削减至25.3亿股","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01530":1},"content_text":"Hong Kong-listed biopharmaceutical group 3SBio Inc. reported that it repurchased 8.52 million ordinary shares in June 2026, transferring all of them into treasury stock.\nThe buy-backs, conducted on 22, 25 and 26 June at average prices of HKD 15.52, HKD 16.00 and HKD 15.91 per share respectively, amounted to an estimated aggregate outlay of about HKD 135.50 million. These transactions were carried out under the general mandate approved on 25 June 2025.\nFollowing the repurchases:\n• Issued shares (excluding treasury stock) decreased by 8.52 million to 2.53 billion, a 0.34% contraction versus May-end.  \n• Treasury shares stood at 8.52 million.  \n• Total issued shares (including treasury stock) remained unchanged at 2.54 billion.  \n• Authorised share capital was unchanged at 50 billion shares with a par value of USD 0.00001 each, equivalent to USD 0.50 million.\n3SBio confirmed that its public float remained above the Hong Kong Main Board’s minimum 25% threshold as at 30 June 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1123839414","isCrawlerRequest":true}